WASHINGTON, D.C. — As Congress continues to consider the Build Back Better Act, AARP and Patients For Affordable Drugs Now sent a letter to members of the House of Representatives today urging them to support the hard-fought agreement to lower drug prices included in the Build Back Better Act. The letter enumerates the key elements of the prescription drug framework, which will lower prices, premiums, and out-of-pocket costs for patients and older Americans. The provisions were added back into the Build Back Better Act after hundreds of thousands of people called and emailed Congress telling members “to stand with us and not the drug companies.” The letter urges representatives to vote yes this week on the Build Back Better Act to lower drug prices for patients. 

“The agreement reached on drug prices will finally start to reverse policies that have left patients and consumers at the mercy of drug corporations and forced Americans to pay three times what other wealthy nations pay for the same medicines,” Nancy A. LeaMond, Executive Vice President and Chief Advocacy and Engagement Officer at AARP, and David Mitchell, cancer patient and founder of Patients For Affordable Drugs Now, say in the letter. “This package represents a hard-fought compromise, and we call on all members of Congress to strongly reject any efforts to weaken the deal.”  

Medicare negotiation is the single most popular element of the Build Back Better plan, with support from 90 percent of Americans. 

Read the full letter here and below.